Mail

UK markets closed

FTSE 100
8,237.72
-34.74(-0.42%)
FTSE 250
20,442.35
-56.35(-0.27%)
AIM
772.57
+0.19(+0.02%)
GBP/EUR
1.1818
-0.0004(-0.03%)
GBP/USD
1.2636
-0.0024(-0.19%)
Bitcoin GBP
50,726.68
-141.18(-0.28%)

Ascletis Pharma Inc. (1672.HK)

HKSE - HKSE Delayed price. Currency in HKD

Add to watchlist

0.900

-0.010

(-1.10%)

At close: 04:08PM HKT

Insider transactions

Insider transactions

Currency in HKD

Insider purchases - Last 6 months	Shares	Trans
Purchases	0	0
Sales	N/A	0
Net shares purchased (sold)	0	0
Total insider shares held	761.18M	N/A
% net shares purchased (sold)	N/A	N/A

Net institutional purchases - Prior quarter to latest quarter	Shares
Net shares purchased (sold)	N/A
% change in institutional shares held	N/A

Insider transactions reported - last two years

Insider	Transaction	Type	Value	Date	Shares
Wu (Jinzi Ph.D.) Chief Executive Officer		Direct		30 Aug 2022	38,000,000
Wu (Hejingdao Judy) Director (Executive)		Direct		30 Aug 2022	38,000,000
Wu (Jinzi Ph.D.) Chief Executive Officer	Acquisition at price 0.39 per share.	Direct	444,009	17 Oct 2019	1,142,000
Wu (Jinzi Ph.D.) Chief Executive Officer	Acquisition at price 0.38 per share.	Direct	201,972	16 Oct 2019	529,000
Wu (Jinzi Ph.D.) Chief Executive Officer	Acquisition at price 0.38 per share.	Direct	112,983	15 Oct 2019	296,000
Wu (Jinzi Ph.D.) Chief Executive Officer	Acquisition at price 0.38 per share.	Direct	131,580	14 Oct 2019	344,000